Abbott competitorsClear all
Abbott's top competitors include Bio-Rad, Philips, Danaher, Pfizer, Roche, Amgen, Johnson & Johnson, Novo Nordisk, Bruker and AbbVie.
| Save Comparison |  Abbott Abbott is a healthcare company specializing in diagnostics, medical devices, nutritionals, and branded generic medicines. |  Bio-Rad Bio-Rad is a company engaged in the life science research and serves clinical diagnostics markets. |  Philips Philips is a company providing diagnostic imaging, image-guided therapy, patient monitoring, and health informatics, as well as in consumer health and home care products. |  Danaher Danaher is a company that designs, manufactures and markets professional, medical, industrial, and commercial products and services. |  Pfizer Pfizer is a research-based biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products. |  Roche Roche (also known as F. Hoffmann-La Roch) is a biotech company operating through 2 segments: Pharmaceuticals and Diagnostics. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products. |  Johnson & Johnson Johnson & Johnson is a global holding company that engages in the research and development, manufacture and sale of a range of products in the healthcare field. |  Bruker Bruker Corporation is a developer, manufacturer, and distributor of scientific instruments and analytical and diagnostic solutions. |  AbbVie AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs. | |
Founding Date | Founding Date 1991 | Founding Date 1952 | Founding Date 1891 | Founding Date 1984 | Founding Date 1849 | Founding Date 1896 | Founding Date 1980 | Founding Date 1886 | Founding Date 1923 | Founding Date 1960 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||||||||
Locations | Locations Lake Bluff, US HQ Tiranë, AL Buenos Aires, AR Yerevan, AM Doncaster, AU Macquarie Park, AU Melbourne, AU see more | Locations Eindhoven, NL HQ Buenos Aires, AR North Ryde, AU Minsk, BY Anderlecht, BE Brussel, BE Zaventem, BE see more | Locations Washington, US HQ Shanghai, CN Mumbai, IN New Delhi, IN Sunbury On Thames, GB | Locations Basel, CH HQ Hydra, DZ Ricardo Rojas, AR Bella Vista, AU North Ryde, AU Sydney, AU Wien, AT see more | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Kew, AU North Ryde, AU Wien, AT Diegem, BE see more | Locations New Brunswick, US HQ Buenos Aires, AR Yerevan, AM Ultimo, AU Wien, AT Minsk, BY Beerse, BE see more | Locations Bagsværd, DK HQ Mississauga, CA Beijing, CN Bagsværd, DK Hellerup, DK Køge, DK Søborg, DK see more | Locations Billerica, US HQ Preston, AU Wien, AT Kontich, BE Atibaia, BR Milton, CA Guangzhou Shi, CN see more | |||
Employees | Employees 107,0004% increase | Employees 8,1202% decrease | Employees 80,4954% increase | Employees 60,00015% decrease | Employees 88,3004% decrease | Employees 94,4421% increase | Employees 23,4009% increase | Employees 132,2002% decrease | Employees 42,0761% increase | Employees 6,87011% increase | Employees 30,000 |
Valuation ($) | Valuation ($) 161.8 b | Valuation ($) 14 b | Valuation ($) 40.1 b | Valuation ($) 111.9 b | Valuation ($) 208.3 b | Valuation ($) N/A | Valuation ($) 133.2 b | Valuation ($) 380.4 b | Valuation ($) N/A | Valuation ($) 6.4 b | Valuation ($) 162.3 b |
Twitter followers | Twitter followers 101.7 k | Twitter followers 43.9 k | Twitter followers 340.3 k | Twitter followers N/A | Twitter followers 18.2 k | Twitter followers 213.8 k | Twitter followers 88.8 k | Twitter followers 196.7 k | Twitter followers 34.4 k | Twitter followers 11.6 k | Twitter followers 62.6 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 297 | Number of tweets (last 30 days) 35 | Number of tweets (last 30 days) 128 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 3 | Number of tweets (last 30 days) 98 | Number of tweets (last 30 days) 75 | Number of tweets (last 30 days) 96 | Number of tweets (last 30 days) 74 | Number of tweets (last 30 days) 100 | Number of tweets (last 30 days) 42 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 14.3 | Average likes per tweet (last 30 days) 3.6 | Average likes per tweet (last 30 days) 0.2 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 12.3 | Average likes per tweet (last 30 days) 33.6 | Average likes per tweet (last 30 days) 25.3 | Average likes per tweet (last 30 days) 15.2 | Average likes per tweet (last 30 days) 8.2 | Average likes per tweet (last 30 days) 4.1 | Average likes per tweet (last 30 days) 19.8 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 51.85% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 12.5% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 98.98% | Percentage of tweets with engagement (last 30 days) 97.33% | Percentage of tweets with engagement (last 30 days) 81.25% | Percentage of tweets with engagement (last 30 days) 51.35% | Percentage of tweets with engagement (last 30 days) 93% | Percentage of tweets with engagement (last 30 days) 90.48% |
Alexa Website Rank | Alexa Website Rank 35563 | Alexa Website Rank 128226 | Alexa Website Rank 6863 | Alexa Website Rank 310036 | Alexa Website Rank 33553 | Alexa Website Rank 91937 | Alexa Website Rank 165413 | Alexa Website Rank 28232 | Alexa Website Rank 196025 | Alexa Website Rank 194160 | Alexa Website Rank 129532 |
Financial | |||||||||||
Revenue (est.) | Revenue (est.) $31.9b (FY, 2019) | Revenue (est.) $2.3b (FY, 2019) | Revenue (est.) €19.5b (FY, 2019) | Revenue (est.) $17.9b (FY, 2019) | Revenue (est.) $51.8b (FY, 2019) | Revenue (est.) CHF59.5b (FY, 2018) | Revenue (est.) $23.4b (FY, 2019) | Revenue (est.) $82.1b (FY, 2019) | Revenue (est.) N/A | Revenue (est.) $2.1b (FY, 2019) | Revenue (est.) $33.3b (FY, 2019) |
Cost of goods | Cost of goods $13.2b (FY, 2019) | Cost of goods $1.1b (FY, 2019) | Cost of goods €10.6b (FY, 2019) | Cost of goods $7.9b (FY, 2019) | Cost of goods $10.2b (FY, 2019) | Cost of goods CHF17.3b (FY, 2018) | Cost of goods $4.4b (FY, 2019) | Cost of goods $27.6b (FY, 2019) | Cost of goods N/A | Cost of goods $1.1b (FY, 2019) | Cost of goods $7.4b (FY, 2019) |
Gross profit | Gross profit $18.7b (FY, 2019) | Gross profit $1.3b (FY, 2019) | Gross profit €8.9b (FY, 2019) | Gross profit $10b (FY, 2019) | Gross profit $41.5b (FY, 2019) | Gross profit CHF42.2b (FY, 2018) | Gross profit $19b (FY, 2019) | Gross profit $54.5b (FY, 2019) | Gross profit N/A | Gross profit $995.3m (FY, 2019) | Gross profit $25.8b (FY, 2019) |
Net income | Net income $3.7b (FY, 2019) | Net income $1.7b (FY, 2019) | Net income €1.2b (FY, 2019) | Net income $3b (FY, 2019) | Net income $16.3b (FY, 2019) | Net income CHF10.9b (FY, 2018) | Net income $7.8b (FY, 2019) | Net income $15.1b (FY, 2019) | Net income N/A | Net income $197.2m (FY, 2019) | Net income $7.9b (FY, 2019) |
Operating ⚠ | |||||||||||
Backlog | Backlog N/A | Backlog N/A | Backlog N/A | Backlog $3.1b (FY, 2019) | Backlog N/A | Backlog N/A | Backlog N/A | Backlog N/A | Backlog N/A | Backlog $1.1b (FY, 2018) | Backlog N/A |
Countries | Countries N/A | Countries N/A | Countries N/A | Countries 60 (FY, 2019) | Countries 125 (FY, 2017) | Countries N/A | Countries 100 (FY, 2019) | Countries 60 (FY, 2018) | Countries N/A | Countries N/A | Countries N/A |
Facilities | Facilities N/A | Facilities N/A | Facilities N/A | Facilities 212 (FY, 2019) | Facilities N/A | Facilities N/A | Facilities 190 (FY, 2019) | Facilities N/A | Facilities N/A | Facilities N/A | Facilities N/A |
Manufacturing Facilities | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities 35 (FY, 2019) | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities 97 (FY, 2019) | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities N/A |
Manufacturing Sites | Manufacturing Sites 92 (FY, 2019) | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites 58 (FY, 2017) | Manufacturing Sites 26 (FY, 2018) | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A |
Patents Issued | Patents Issued N/A | Patents Issued 2 k (FY, 2018) | Patents Issued 1 k (FY, 2019) | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A |
Patients | Patients N/A | Patients N/A | Patients N/A | Patients N/A | Patients N/A | Patients 127 m (FY, 2018) | Patients N/A | Patients N/A | Patients N/A | Patients N/A | Patients 30 m (FY, 2018) |
Patients Included in Clinical Trials | Patients Included in Clinical Trials N/A | Patients Included in Clinical Trials N/A | Patients Included in Clinical Trials N/A | Patients Included in Clinical Trials N/A | Patients Included in Clinical Trials N/A | Patients Included in Clinical Trials 279.5 k (FY, 2018) | Patients Included in Clinical Trials N/A | Patients Included in Clinical Trials N/A | Patients Included in Clinical Trials N/A | Patients Included in Clinical Trials N/A | Patients Included in Clinical Trials 104 k (FY, 2018) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 29 (FY, 2017) | Phase III Trials Products N/A | Phase III Trials Products 14 (Feb, 2020) | Phase III Trials Products N/A | Phase III Trials Products 3 (FY, 2016) | Phase III Trials Products N/A | Phase III Trials Products N/A |
Products | Products 1.5 k (FY, 2018) | Products 9 k (FY, 2018) | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A |
Research and Development Centers | Research and Development Centers 12 (FY, 2017) | Research and Development Centers N/A | Research and Development Centers N/A | Research and Development Centers N/A | Research and Development Centers N/A | Research and Development Centers 30 (FY, 2018) | Research and Development Centers N/A | Research and Development Centers N/A | Research and Development Centers N/A | Research and Development Centers N/A | Research and Development Centers N/A |
Suppliers | Suppliers N/A | Suppliers N/A | Suppliers 4.9 k (FY, 2019) | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers 3.5 k (Jun, 2018) | Suppliers N/A | Suppliers N/A | Suppliers 51 k (FY, 2018) |
Funding | |||||||||||
Total funding raised | Total funding raised $ 6.9m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 2.8b | Total funding raised $ 175.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 22.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Bio-Rad
HQ
Hercules, US
Employees
8,120↓ 2% decrease
Bio-Rad is a company engaged in the life science research and serves clinical diagnostics markets.
View companyPhilips
HQ
Eindhoven, NL
Employees
80,495↑ 4% increase
Philips is a company providing diagnostic imaging, image-guided therapy, patient monitoring, and health informatics, as well as in consumer health and home care products.
View companyDanaher
HQ
Washington, US
Employees
60,000↓ 15% decrease
Danaher is a company that designs, manufactures and markets professional, medical, industrial, and commercial products and services.
View companyPfizer
HQ
New York, US
Employees
88,300↓ 4% decrease
Pfizer is a research-based biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products.
View company